Report an error

Spotted something inaccurate in “Low hsa-miR-145-3p Associated with Fibro-Inflammatory Bladder Cancer Subtype Vulnerable to Dasatinib”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.